P. Andujar , B. Fervers , F. Delva , B. Clin , J.-C. Pairon
{"title":"法国、比利时和瑞士支气管癌的流行病学--主要环境和职业风险因素","authors":"P. Andujar , B. Fervers , F. Delva , B. Clin , J.-C. Pairon","doi":"10.1016/S1877-1203(24)00069-7","DOIUrl":null,"url":null,"abstract":"<div><div>In France, Belgium and Schwizerland, respectively, lung cancer is the 3rd most common cancer and the 1st cause of cancer-related death. While incidence and mortality rates in men have stabilized, they are demonstrating an alarming growth in women, linked to the increase in female tobacco consumption. Combined, close to 90% of lung cancer cases are attributable to modifiable factors, offering numerous levers for prevention policies. While tobacco smoking is indeed the main risk factor for lung cancer, responsible for 80% of cases, the risk factors and exposures are numerous, such as a diet low in fruit (10% of cases), occupational exposures (15% of cases), and environmental exposures, such as radon (almost 10% of cases) and outdoor air pollution (3.6% of cases). The proportion of environmental exposures are probably underestimated. In 2024, the International Agency for Research on Cancer identified more than 30 definite carcinogen agents (and carcinogenic exposure situations from all sources) for which there is an excess of lung cancer in occupational settings. In the clinical management of pneumology patients, it is important to identify any exposure to carcinogenic agents. Recognition of lung cancer as an occupational disease is a major medical and social issue for patients. Several approaches can be used to identify exposure to occupational carcinogens: occupational interview (with specific questionnaires or self-questionnaires), biometrological analysis for certain agents, or imaging. Once an occupational exposure has been identified, the clinician may or may not advise the patient to file an occupational disease claim.</div></div>","PeriodicalId":53645,"journal":{"name":"Revue des Maladies Respiratoires Actualites","volume":"16 2","pages":"Pages 2S3-2S9"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Épidémiologie du cancer bronchique en France, Belgique et Suisse – Principaux facteurs de risque environnementaux et professionnels\",\"authors\":\"P. Andujar , B. Fervers , F. Delva , B. Clin , J.-C. Pairon\",\"doi\":\"10.1016/S1877-1203(24)00069-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>In France, Belgium and Schwizerland, respectively, lung cancer is the 3rd most common cancer and the 1st cause of cancer-related death. While incidence and mortality rates in men have stabilized, they are demonstrating an alarming growth in women, linked to the increase in female tobacco consumption. Combined, close to 90% of lung cancer cases are attributable to modifiable factors, offering numerous levers for prevention policies. While tobacco smoking is indeed the main risk factor for lung cancer, responsible for 80% of cases, the risk factors and exposures are numerous, such as a diet low in fruit (10% of cases), occupational exposures (15% of cases), and environmental exposures, such as radon (almost 10% of cases) and outdoor air pollution (3.6% of cases). The proportion of environmental exposures are probably underestimated. In 2024, the International Agency for Research on Cancer identified more than 30 definite carcinogen agents (and carcinogenic exposure situations from all sources) for which there is an excess of lung cancer in occupational settings. In the clinical management of pneumology patients, it is important to identify any exposure to carcinogenic agents. Recognition of lung cancer as an occupational disease is a major medical and social issue for patients. Several approaches can be used to identify exposure to occupational carcinogens: occupational interview (with specific questionnaires or self-questionnaires), biometrological analysis for certain agents, or imaging. Once an occupational exposure has been identified, the clinician may or may not advise the patient to file an occupational disease claim.</div></div>\",\"PeriodicalId\":53645,\"journal\":{\"name\":\"Revue des Maladies Respiratoires Actualites\",\"volume\":\"16 2\",\"pages\":\"Pages 2S3-2S9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue des Maladies Respiratoires Actualites\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1877120324000697\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue des Maladies Respiratoires Actualites","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1877120324000697","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
在法国、比利时和瑞士,肺癌分别是第三大常见癌症和第一大癌症致死原因。虽然男性的发病率和死亡率已趋于稳定,但女性的发病率和死亡率却出现了惊人的增长,这与女性烟草消费的增加有关。总之,近 90% 的肺癌病例可归因于可改变的因素,这为预防政策提供了许多杠杆。虽然吸烟确实是肺癌的主要风险因素,占肺癌病例的 80%,但风险因素和暴露也很多,如饮食中水果含量低(占病例的 10%)、职业暴露(占病例的 15%)以及环境暴露,如氡(占病例的近 10%)和室外空气污染(占病例的 3.6%)。环境暴露的比例可能被低估了。2024 年,国际癌症研究机构(International Agency for Research on Cancer)确定了 30 多种明确的致癌物质(以及各种来源的致癌接触情况),这些致癌物质在职业环境中导致肺癌发病率过高。在对肺病患者进行临床治疗时,必须查明是否接触过致癌物质。将肺癌认定为职业病对患者来说是一个重大的医疗和社会问题。有几种方法可用于确定是否接触过职业致癌物:职业访谈(特定问卷或自我问卷)、针对某些致癌物的生物计量学分析或成像。一旦确定职业接触,临床医生可以建议病人提出职业病索赔,也可以不建议病人提出职业病索赔。
Épidémiologie du cancer bronchique en France, Belgique et Suisse – Principaux facteurs de risque environnementaux et professionnels
In France, Belgium and Schwizerland, respectively, lung cancer is the 3rd most common cancer and the 1st cause of cancer-related death. While incidence and mortality rates in men have stabilized, they are demonstrating an alarming growth in women, linked to the increase in female tobacco consumption. Combined, close to 90% of lung cancer cases are attributable to modifiable factors, offering numerous levers for prevention policies. While tobacco smoking is indeed the main risk factor for lung cancer, responsible for 80% of cases, the risk factors and exposures are numerous, such as a diet low in fruit (10% of cases), occupational exposures (15% of cases), and environmental exposures, such as radon (almost 10% of cases) and outdoor air pollution (3.6% of cases). The proportion of environmental exposures are probably underestimated. In 2024, the International Agency for Research on Cancer identified more than 30 definite carcinogen agents (and carcinogenic exposure situations from all sources) for which there is an excess of lung cancer in occupational settings. In the clinical management of pneumology patients, it is important to identify any exposure to carcinogenic agents. Recognition of lung cancer as an occupational disease is a major medical and social issue for patients. Several approaches can be used to identify exposure to occupational carcinogens: occupational interview (with specific questionnaires or self-questionnaires), biometrological analysis for certain agents, or imaging. Once an occupational exposure has been identified, the clinician may or may not advise the patient to file an occupational disease claim.